XENOTHERA
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases. Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovates passive immunotherapy by marketing a new generation of hyperimmune polyclonal sera. Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.
XENOTHERA
Industry:
Biotechnology Genetics Therapeutics
Founded:
2014-01-01
Address:
Nantes, Pays De La Loire, France
Country:
France
Website Url:
http://www.xenothera.com
Total Employee:
1+
Status:
Active
Contact:
+33240412987
Email Addresses:
[email protected]
Total Funding:
24.35 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Alector
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
iBio
iBio is a technology platform that develops pharmaceutical product applications.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Employees Featured
Founder
Investors List
Didier Rousseau
Didier Rousseau investment in Series C - Xenothera
SC NABUBOTO
SC NABUBOTO investment in Series C - Xenothera
European Innovation Council
European Innovation Council investment in Grant - Xenothera
Malakoff Humanis
Malakoff Humanis investment in Series C - Xenothera
Anaxago
Anaxago investment in Series C - Xenothera
European Innovation Council
European Innovation Council investment in Series C - Xenothera
Bpifrance
Bpifrance investment in Grant - Xenothera
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Xenothera
Starquest Capital
Starquest Capital investment in Seed Round - Xenothera
Arts et Métiers Business Angels
Arts et Métiers Business Angels investment in Seed Round - Xenothera
Official Site Inspections
http://www.xenothera.com Semrush global rank: 3.37 M Semrush visits lastest month: 4.68 K
- Host name: webcluster16.webpod10-cph3.one.com
- IP address: 77.111.240.79
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Xenothera"
Xenothera - Crunchbase Company Profile & Funding
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from …See details»
Team – XENOTHERA
Chairman and founder. More PhilippeSee details»
Mission – XENOTHERA
That’s why at XENOTHERA, we’re determined to get things moving. To bring disruptive and useful treatments to patients. We manufacture glyco-humanized polyclonal antibodies. More …See details»
Xenothera - Overview, News & Similar companies | ZoomInfo.com
May 30, 2023 XENOTHERA is a biotechnology start-up company which creates new therapeutic modes in immunomodulation, infectious diseases and oncology. ... which will be carried out by …See details»
XENOTHERA - healthtechinnovationdays6.com
XENOTHERA is a clinical stage biotech company developing First-In-Class drugs mainly in oncology and haematology. Our disruptive immunotherapy, based on a patented platform of …See details»
Xenothera Company Profile 2024: Valuation, Funding & Investors
Xenothera General Information Description. Developer of immunosuppressants designed for transplantation and other indications. The company developed a Glyco-humanized antibody …See details»
Xenothera SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Xenothera SAS with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 3 news, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases ...See details»
Xenothera - Org Chart, Teams, Culture & Jobs - The Org
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from …See details»
Xenothera Company Profile - Office Locations, Competitors ... - Craft
Xenothera is a clinical-stage biotech company specializing in therapeutic for immunological treatments. It develops approaches in immunotherapy utilizing glyco-humanized polyclonal …See details»
Xenothera - Funding, Financials, Valuation & Investors - Crunchbase
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Xenothera - VentureRadar
Find out more about Xenothera including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) …See details»
Xenothera - Company Profile - Tracxn
Nov 5, 2024 Xenothera - French biotech developing immunosuppressants for transplantation and other indications. Raised a total funding of $3.27M over 6 rounds from 7 investors. …See details»
Xenothera - Contacts, Employees, Board Members, Advisors
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.See details»
☑️Xenothera — Consulting Organization from France, …
Xenothera — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Research sectorsSee details»
XENOTHERA - European Commission - European Innovation Council
XENOTHERA is a clinical stage biotech at the top of innovation, which creates new therapeutic modes in numerous domains. Xenothera's patented technological platform is built on a double …See details»
pipeline – XENOTHERA
At the 36th ENA - EORTC - AACR symposium, Firas Bassissi, XENOTHERA CSO, presented highly promising results in pancreatic cancer. Read More XENOTHERA ANNOUNCES THE …See details»
Xenothera Company Information - Funding, Investors, and More
Jan 1, 2020 Get information on funding, investors, industries, and more for Xenothera. See Xenothera company profile and funding data.See details»
Xenothera: innovative antibodies for new perspectives in the fight ...
Dec 2, 2024 At the same time, Xenothera is making progress on other treatments that could have a major impact in oncology. XON7: This drug targets solid tumours. Clinical trials began …See details»
XENOTHERA presents XON11, a new hope for the treatment of …
Oct 29, 2024 These results, published by XENOTHERA at the Barcelona congress, offer definite hope for patients suffering from pancreatic cancer. This particularly aggressive cancer affects …See details»